EGFR-TK1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EGFR-TK1, covering 2019-01-22 to 2019-01-22. Get the full timeline:
Most recent: Clinical Trial Update: The Efficacy and Drug Resistance Molecular Biology of Apatinib Combined With EGFR-TK1 Treated for Advanced Slow-progressed Non-Small Cell Lung Cancer (NSCLC) [Phase 2]